Arias named AAC Editor-in-Chief

By Roman Petrowski, Office of Communications

Cesar Arias, MD, PhD

Cesar Arias, MD, PhD, Margaret and Herbert DuPont Chair in Infectious Disease and professor of internal medicine, has been named the editor-in-chief of Antimicrobial Agents and Chemotherapy (AAC), an interdisciplinary journal produced by the American Society for Microbiology (ASM). Arias’ term begins July 1, 2020.

According to the ASM, Antimicrobial Agents and Chemotherapy is devoted to the dissemination of knowledge relating to all aspects of antimicrobial and antiparasitic agents and chemotherapy.

Arias, an internationally recognized expert, holds the Laurel and Robert H. Graham Faculty Fellowship at UTHealth. He is the founding director of the Center for Antimicrobial Resistance and Microbial Genomics (CARMiG) and the Center of Infectious Diseases at the UTHealth School of Public Health.

Arias, an adjunct professor at Universidad El Bosque in Bogota, Colombia, focuses on conducting basic, translational and clinical research on antibiotic resistance. He was inducted into the American Academy of Microbiology in 2019 and has served as an AAC editorial board member since 2009 and as an editor since 2014.

ASM is one of the largest professional societies dedicated to the life sciences and is composed of 30,000 scientists and health practitioners. ASM’s mission is to promote and advance the microbial sciences.